Optina's Landmark REPHRASE Study to Validate an Innovative Cerebral Amyloid Status Test for the Diagnosis and Management of Alzheimer's Disease
/PRNewswire/ -- Optina Diagnostics' pioneering pivotal REPHRASE study, currently underway, is poised to revolutionize the diagnosis and management of...